Page last updated: 2024-09-05

sb 203580 and Weight Reduction

sb 203580 has been researched along with Weight Reduction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Drillenburg, P; Peppelenbosch, MP; Pronk, I; ten Hove, T; van den Blink, B; van Deventer, SJ	1

Other Studies

1 other study(ies) available for sb 203580 and Weight Reduction

Article	Year
Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis. Gut, 2002, Volume: 50, Issue:4 Topics: Animals; Blotting, Western; Colitis; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Imidazoles; Interferon-gamma; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; T-Lymphocytes; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Wasting Syndrome; Weight Loss	2002

Article

Year

Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.

Gut, 2002, Volume: 50, Issue:4

Topics: Animals; Blotting, Western; Colitis; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Imidazoles; Interferon-gamma; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; T-Lymphocytes; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Wasting Syndrome; Weight Loss

2002